ARC-520 Phase 1
I thought the Phase I on healthy volunters was over with 36 subjects.
Back on October 9, 2013 this was reported:
The study was planned to enroll 36 subjects in six cohorts of six subjects each, with 2 subjects receiving placebo and 4 receiving ARC-520. The study successfully enrolled all 36 subjects (24 received ARC-520, 12 placebo) at a single center in Melbourne, Australia. All subjects received their full, assigned dose and there were no discontinuations for adverse events or otherwise.
I see now they are saying Phase I is active with Estimated Enrollment of 48 on the Clinical Website. I may be incorrect but I thought the phase I was completed at the beginning of March but now I see it is still enrolling. Did I miss something and was it always planned to enroll 48 people? Hope someone that has followed this closer than I can clarify.